Exercise to Boost Response to Checkpoint Blockade Immunotherapy

NCT05358938 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Melanoma
Cutaneous Squamous Cell Carcinoma
Merkel Cell Carcinoma

Interventions

OTHER: Exercise
DRUG: Checkpoint Blockade, Immune

Sponsor

H. Lee Moffitt Cancer Center and Research Institute